---
title: "RBC Capital Reaffirms Their Buy Rating on Magnite (MGNI)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284475982.md"
description: "RBC Capital analyst Matthew Swanson has reaffirmed a Buy rating on Magnite (MGNI) with a price target of $23.00, while the shares closed at $13.03. The analyst consensus on Magnite is a Strong Buy, with an average price target of $24.11. Swanson has an average return of -7.4% and a 37.21% success rate on his stock recommendations."
datetime: "2026-04-29T01:49:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284475982.md)
  - [en](https://longbridge.com/en/news/284475982.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284475982.md)
---

# RBC Capital Reaffirms Their Buy Rating on Magnite (MGNI)

RBC Capital analyst Matthew Swanson maintained a Buy rating on Magnite on April 27 and set a price target of $23.00. The company’s shares closed yesterday at $13.03.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Swanson covers the Technology sector, focusing on stocks such as DoubleVerify Holdings, Adobe, and Zeta Global Holdings Corp. According to TipRanks, Swanson has an average return of \-7.4% and a 37.21% success rate on recommended stocks.

Currently, the analyst consensus on Magnite is a Strong Buy with an average price target of $24.11.

### Related Stocks

- [MGNI.US](https://longbridge.com/en/quote/MGNI.US.md)
- [DV.US](https://longbridge.com/en/quote/DV.US.md)
- [ADBE.US](https://longbridge.com/en/quote/ADBE.US.md)
- [ZETA.US](https://longbridge.com/en/quote/ZETA.US.md)

## Related News & Research

- [Assessing Magnite (MGNI) Valuation After An Earnings Beat And CTV Plus AI Growth Momentum](https://longbridge.com/en/news/286141219.md)
- [Magnite Earnings: What To Look For From MGNI](https://longbridge.com/en/news/285147498.md)
- [Magnite (NASDAQ:MGNI) Posts Earnings Results](https://longbridge.com/en/news/285479470.md)
- [LifeSci Capital Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)](https://longbridge.com/en/news/286679129.md)
- [Jefferies Reaffirms Their Buy Rating on Devon Energy (DVN)](https://longbridge.com/en/news/286728558.md)